Long-Term Storage Effects on Stability of Aβ1–40, Aβ1–42, and Total Tau Proteins in Human Plasma Samples Measured with Immunomagnetic Reduction Assays
Dementia and Geriatric Cognitive Disorders Extra · 12.02.2019 · 9 (1) · 77-86
DOI: 10.1159/000496099 ↗Kurz gefasst
Fachartikel in der Zeitschrift Dementia and Geriatric Cognitive Disorders Extra, online erschienen am 12.02.2019. Verfasst von Ming-Jang Chiu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, College of Medicine, National Taiwan University Hospital, National Taiwan University, Taipei, Taiwan. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
The stability of Alzheimer’s disease (AD) biomarkers in plasma, measured by immunomagnetic reduction (IMR) after long-term storage at –80°C, has not been established before.
Method
Ninety-nine human plasma samples from 53 normal controls (NCs), 5 patients with amnestic mild cognitive impairment (aMCI), and 41 AD patients were collected. Each plasma sample was aliquoted and stored as single-use aliquots at –80°C. The baseline measurements for Aβ1–40, Aβ1–42, and total Tau protein (T-Tau) concentrations for each sample were done within 3 months of blood draw by IMR. They are referred to as baseline concentrations. A separate aliquot from each sample was assayed with IMR to assess the stability of the measured analytes during storage at –80°C between 1.1 and 5.4 years. This is referred to as a repeated result.
Results
IMR shows that plasma levels of Aβ1–40 and Aβ1–42 exhibit stability over 5-year storage at –80°C and that plasma levels of T-Tau are less stable (approximately 1.5 years).
Conclusion
Although the measured concentrations of T-Tau in human plasma may alter during storage, the diagnostic utility of the results are only slightly affected when the product of Aβ1–42 and T-Tau concentrations are used. The results show that the overall agreement between baseline and repeated measurements in the ability of discriminating NCs from aMCI/AD patients is higher than 80%.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, College of Medicine, National Taiwan University Hospital, National Taiwan University, Taipei, Taiwan.
- Graduate Institute of Brain and Mind Sciences, College of Medicine, National Taiwan University, Taipei, Taiwan.
- Department of Psychology, National Taiwan University, Taipei, Taiwan.
- Laboratory of Neuroregeneration, Banner Sun Health Research Institute, Sun City, Arizona, USA.
- Biodesign Institute, Banner Neurodegenerative Disease Research Center, Arizona State University, Tempe, Arizona, USA.
- Lou Ruvo Center for Brain Health Cleveland Clinic, Las Vegas, Nevada, USA.
Zitieren
APA
Chiu, M. J., Lue, L. F., Sabbagh, M. N., Chen, T. F., Chen, H. H., & Yang, S. Y. (2019). Long-Term Storage Effects on Stability of Aβ1–40, Aβ1–42, and Total Tau Proteins in Human Plasma Samples Measured with Immunomagnetic Reduction Assays. Dementia and Geriatric Cognitive Disorders Extra, 9(1), 77-86. https://doi.org/10.1159/000496099
Vancouver
Chiu MJ, Lue LF, Sabbagh MN, Chen TF, Chen HH, Yang SY. Long-Term Storage Effects on Stability of Aβ1–40, Aβ1–42, and Total Tau Proteins in Human Plasma Samples Measured with Immunomagnetic Reduction Assays. Dementia and Geriatric Cognitive Disorders Extra. 2019;9(1):77-86. doi:10.1159/000496099
BibTeX
@article{Chiu2019,
author = {Chiu, Ming-Jang and Lue, Lih-Fen and Sabbagh, Marwan N and Chen, Ta-Fu and Chen, H H and Yang, Shieh-Yueh},
title = {Long-Term Storage Effects on Stability of Aβ1–40, Aβ1–42, and Total Tau Proteins in Human Plasma Samples Measured with Immunomagnetic Reduction Assays},
journal = {Dementia and Geriatric Cognitive Disorders Extra},
year = {2019},
volume = {9},
number = {1},
pages = {77--86},
doi = {10.1159/000496099}
}
EUVIMED